- Commissioner’s statement on Ventura, Marte
- Ronnie O’Sullivan: Masters champion ‘felt so vulnerable’ in final
- Arron Fletcher Wins 2017 WSOP International Circuit Marrakech Main Event ($140,224)
- Smith challenges Warner to go big in India
- Moncada No. 1 on MLB Pipeline’s Top 10 2B Prospects list
- Braves land 2 on MLB Pipeline’s Top 10 2B Prospects list
- Kingery makes MLB Pipeline’s Top 10 2B Prospects list
- New Zealand wrap up 2-0 after Bangladesh implosion
- Mathews, Pradeep, Gunathilaka to return to Sri Lanka
- Elliott hopes for rain for Poli
Nevada Athletic Commission Confirms Jon Jones’ June 16 Test Positive for Estrogen Blockers
- Updated: July 18, 2016
It turns out Rashad Evans was correct. In a hearing on Monday, the Nevada Athletic Commission announced that former UFC light heavyweight champion Jon Jones’ failed June 16 out-of-competition anti-doping test — the test that nixed his scheduled rematch at UFC 200 versus Daniel Cormier — was for two estrogen-blocking substances. NAC attorney Caroline Bateman stated revealed that Jones tested positive for both the anti-estrogenic agent hydroxyclomiphene as well as letrozole metabolite, an aromatase inhibitor. In male athletes, estrogen blockers and aromatase inhibitors are often used to both mask the use of exogenous steroids, help restart natural testosterone production, as well as potential physical symptoms …
continue reading in source www.sherdog.com